Jaiwant Rangi, MD, FACEEndocrinologist | Founder, Lower The Dose® | Speaker

Rethinking Diabetes Care: Shifting the Focus from Numbers to Organ Protection

30 Jul 2026 · 1 min

Watch on YouTube

0:33

In this segment, Dr. Jaiwant Rangi argues that the traditional focus on lowering A1C in diabetes management is merely a surrogate for the real objective: extending the years a patient lives with healthy heart, kidneys, and brain. He proposes a paradigm shift that places organ protection at the forefront of treatment decisions. Consequently, medication selection should be based on agents that both lower glucose and confer cardiovascular, renal, and neuroprotective benefits, reframing the clinical question from "how low can we get the sugar?" to "how safe are the patient's organs?"

Chapters

A normal A1C was never the real goal. It was stand-in for what we actually want: more years, more living with your heart, kidneys, and brain intact. The new model flips it. Ask first what protects your organs. So any medication that we want to choose has to do more than just the blood sugar, and then choose the tools that lower the sugar and defend the body at the same time. The question is no longer how low is your sugar. The question is how safe are your organs? Jaiwant Rangi.